Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USADA Builds Team To Change Supplement Law, Cites "Lax" Regulations

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Anti-Doping Agency leads an alliance seeking stronger enforcement against steroid-containing nutritional supplements, proposing legislative changes that could significantly burden FDA and supplement manufacturers, retailers and distributors

You may also be interested in...



One-Two Punch On Supplements From Former FDA Investigator, Harvard Researchers

Jeff Novitzky, VP of athlete health and performance at Ultimate Fighting Championship, discusses violative supplements at a Dietary Supplement Caucus briefing for lawmakers and congressional staff. Harvard researchers roundly criticize the products' potential health benefits.

N.Y. Supplement Marketing Restriction Bill Raises Specter Of Copycats

Stakeholders fear legislation proposed in New York to restrict sports supplement sales to consumers 18 and older and to require additional labeling could inspire copy-cats in other states. Trade groups say DSHEA already covers the proposed legislation’s goals.

N.Y. Supplement Marketing Restriction Bill Raises Specter Of Copycats

Stakeholders fear legislation proposed in New York to restrict sports supplement sales to consumers 18 and older and to require additional labeling could inspire copy-cats in other states. Trade groups say DSHEA already covers the proposed legislation’s goals.

Related Content

Topics

UsernamePublicRestriction

Register

PS103604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel